Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04994067 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intra-Operative Radiation Registry

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 500 to 460
    • Eligibility criteria expanded, about 13 words
    • Publications: details revised at 11 of 11 entries
  2. Enrollment target: 250 to 500v6 Show 4 more changesShow less
    • Primary completion date: Aug 2029 to Jan 2028
    • Study completion date: Aug 2029 to Aug 2032
    • Study description expanded, about 6 words
    • Eligibility criteria expanded, about 1 word
  3. Primary and study completion dates: Aug 2024 to Aug 2029v5
  4. Re-verified, no change to tracked fieldsv4
  5. Primary completion date: Aug 9, 2023 to Aug 2024
    • Study completion date: Aug 9, 2024 to Aug 2024
    v3
  6. Eligibility criteria expanded, about 7 wordsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This registry trial is designed to track the local control rates and side effects of IORT, which will be implemented for women who are suitable partial breast irradiation (PBI) per the latest American Society of Radiation Oncology (ASTRO) guidelines.
Trial Details
NCT Number NCT04994067
Lead Sponsor Albert Einstein College of Medicine
Conditions
(from sponsor)		 Breast Cancer
Related terms Breast Neoplasms
Enrollment 460 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov